Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Apellis Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APLS.
You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.
Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Ascentage Pharma Group (NASDAQ:AAPG).
Apellis Pharmaceuticals has a consensus price target of $49.58.
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $17.82 last updated April 24, 2025 at 4:19 PM EDT.
There are no upcoming dividends for Apellis Pharmaceuticals.
Apellis Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Apellis Pharmaceuticals.
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.